Pricing and Reimbursement. Subject to Section 6.2(c), RMS will be responsible for pricing and reimbursement of RMS Products in line with market conditions and in accordance with RMS’ global pricing strategies. The Parties will discuss and agree upon a joint strategy to work with Third Party payors to establish the value of the RMS Product, for such Third Party payors, in the Major Markets. RMS agrees to use Commercially Reasonable Efforts to establish the value of the RMS Product, on a country-by-country basis in the Major Markets, consistent with similar IVD products commercialized by RMS in such country in the Major Markets.
Appears in 4 contracts
Samples: Companion Diagnostics Agreement (Epizyme, Inc.), Companion Diagnostics Agreement, Companion Diagnostics Agreement (Epizyme, Inc.)